Results 41 to 50 of about 263,960 (292)
Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model [PDF]
, 2020 Background: The prevalence of human infections with the zoonotic pathogen Campylobacter jejuni is rising worldwide. Therefore, the identification of compounds with potent anti-pathogenic and anti-inflammatory properties for future therapeutic and/or ...
Bereswill, Stefan +7 more
core +1 more source
Insights into PI3K/AKT signaling in B cell development and chronic lymphocytic leukemia
FEBS Letters, EarlyView.This Review explores how the phosphoinositide 3‐kinase and protein kinase B pathway shapes B cell development and drives chronic lymphocytic leukemia, a common blood cancer. It examines how signaling levels affect disease progression, addresses treatment challenges, and introduces novel experimental strategies to improve therapies and patient outcomes.
Maike Buchner
wiley +1 more source
Revista Brasileira de Hematologia e Hemoterapia, 2004 This paper describes the tomographic appearance of pulmonary lymphomas. We studied the thoracic computed tomographies of ten patients with biopsy-proven diagnoses non-Hodgkin's and Hodgkin's disease. The most common radiologic findings in this series are
Edson Marchiori +2 more
doaj +1 more source
Therapeutic Advances in Hematology, 2022 Background: Pain, a common symptom of hemophilia, begins early in life primarily due to joint bleeding. Recurrent bleeding adversely affects patients’ pain-related physical functioning, which can negatively impact their quality of life (QoL).
John Pasi +6 more
doaj +1 more source
FEBS Letters, EarlyView.Low‐density lipoprotein receptor‐related protein 6 (LRP6) is a key receptor for the Wnt antagonist Dickkopf1 (DKK1). DKK1 protein expression is induced in a bleomycin (BLM)‐induced lung injury model. We show that DKK1 induces proinflammatory and profibrotic genes in lung fibroblasts.
Eun‐Ah Sung +6 more
wiley +1 more source
Mantle cell lymphoma management trends and novel agents: where are we going?
Therapeutic Advances in Hematology, 2022 The heterogeneity in disease pathology, the unpredictability in disease prognosis, and the variability in response to therapy make mantle cell lymphoma (MCL) a focus of novel therapeutic development.
Jeffrey J. Pu +3 more
doaj +1 more source
Indications for Synergetic and Antagonistic Effects between Trace Elements in The Environment to Human Health [PDF]
, 2007 The objective of this work was to investigate the interactions between the level of concentrations of Ca, V, Cr, Mn, Fe, Ni, Cu, Zn, As and Pb in potable water, soil, vegetation and school children hair and disease incidences of neoplasms, diseases of ...
Ante Kutle +3 more
core +1 more source
Taurine promotes glucagon‐like peptide‐1 secretion in enteroendocrine L cells
FEBS Letters, EarlyView.Taurine, a sulfur‐containing amino acid, is likely taken up by enteroendocrine L cells via the taurine transporter. This process increases the levels of cytosolic ATP. The increase in intracellular Ca2+ concentrations and glucagon‐like peptide‐1 secretion through membrane depolarization is caused by the closure of ATP‐sensitive potassium channels ...
Yuri Osuga +6 more
wiley +1 more source
Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL)
Therapeutic Advances in Hematology, 2022 Mantle cell lymphoma (MCL) is a rare B-cell malignancy that remains challenging to treat with high rates of relapse. Frontline strategies range from intensive chemotherapy followed by consolidation with autologous stem cell transplant (ASCT), to less ...
Bushra Tbakhi, Patrick M. Reagan
doaj +1 more source
Herbal Remedies for Combating Irradiation: a Green Antiirradiation Approach [PDF]
, 2014 Plants play important roles in human life not only as suppliers of oxygen but also as a fundamental resource to sustain the human race on this earthly plane.
Choong, Y. S. +8 more
core +1 more source